Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 12/20 | 0.66 |
| ▸ | CYP3A4 | P08684 | 11/20 | 0.66 |
| ▸ | CLK4 | Q9HAZ1 | 9/20 | 0.66 |
| ▸ | USP2 | O75604 | 9/20 | 0.66 |
| ▸ | CYP2D6 | P10635 | 8/20 | 0.66 |
| ▸ | MEN1 | O00255 | 9/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 9/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.66 |
| ▸ | CYP2C19 | P33261 | 7/20 | 0.66 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.66 |
| ▸ | LMNA | P02545 | 6/20 | 0.66 |
| ▸ | MAPK1 | P28482 | 5/20 | 0.66 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.66 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.66 |
| ▸ | CYP2C9 | P11712 | 6/20 | 0.61 |
| ▸ | TSHR | P16473 | 5/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.60 |
| ▸ | TP53 | P04637 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 1/20 | 0.60 |
| ▸ | HPGD | P15428 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1084040 | 0.93 | GSK3B (0.60) | CYP1A2CYP3A4CLK4USP2CYP2D6 | |
| SCHEMBL13300270 | 0.91 | CYP1A2 (0.55) | CYP1A2CYP3A4CLK4USP2CYP2D6 | |
| SCHEMBL1083790 | 0.89 | GSK3B (0.56) | CYP1A2CYP3A4CLK4USP2CYP2D6 | |
| SCHEMBL13300202 | 0.88 | CYP1A2 (0.64) | CYP1A2CYP3A4CLK4USP2CYP2D6 | |
| SCHEMBL13300091 | 0.87 | CYP1A2 (0.53) | CYP1A2CYP3A4CLK4USP2CYP2D6 | |
| SCHEMBL13300044 | 0.87 | CYP1A2 (0.50) | CYP1A2CYP3A4CLK4USP2CYP2D6 | |
| SCHEMBL13300127 | 0.87 | GBA1 (0.63) | CYP1A2CYP3A4CLK4USP2CYP2D6 | |
| SCHEMBL1083896 | 0.87 | GSK3B (0.54) | CYP1A2CYP3A4CLK4USP2CYP2D6 | |
| SCHEMBL13300322 | 0.86 | GSK3B (0.53) | CYP1A2CYP3A4CLK4USP2CYP2D6 | |
| SCHEMBL10284426 | 0.86 | MEN1 (0.57) | CYP1A2CYP3A4CLK4USP2CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2198867-A1 | Pyrimidine-based compounds useful as GSK-3 inhibitors | Vertex Pharmaceuticals, Inc. (US) | 2010-06-23 | — | — | EP | disclosed |
| EP-1474147-B1 | PYRIMIDINE-BASED COMPOUNDS USEFUL AS GSK-3 INHIBITORS | VERTEX PHARMA (US) | 2010-05-05 | — | — | EP | disclosed |
| US-20030199526-A1 | Pyrimidine-based compounds useful as GSK-3 inhibitors | VERTEX PHARMACEUTICALS, INCORPORATED | 2003-10-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030199526-A1 | Pyrimidine-based compounds useful as GSK-3 inhibitors | GSK3B, GSK3A, GSKIP | CYP1A2 2209/4885CYP3A4 2517/4885CLK4 1089/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.